113 related articles for article (PubMed ID: 9617921)
1. SNAP-25 deficit and hippocampal connectivity in schizophrenia.
Young CE; Arima K; Xie J; Hu L; Beach TG; Falkai P; Honer WG
Cereb Cortex; 1998; 8(3):261-8. PubMed ID: 9617921
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
3. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
[TBL] [Abstract][Full Text] [Related]
4. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
[TBL] [Abstract][Full Text] [Related]
5. Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils.
Ishimaru H; Casamenti F; Uéda K; Maruyama Y; Pepeu G
Brain Res; 2001 Jun; 903(1-2):94-101. PubMed ID: 11382392
[TBL] [Abstract][Full Text] [Related]
6. Lesions of hippocampal circuitry define synaptosomal-associated protein-25 (SNAP-25) as a novel presynaptic marker.
Geddes JW; Hess EJ; Hart RA; Kesslak JP; Cotman CW; Wilson MC
Neuroscience; 1990; 38(2):515-25. PubMed ID: 1702194
[TBL] [Abstract][Full Text] [Related]
7. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
[TBL] [Abstract][Full Text] [Related]
8. Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway.
Barr AM; Young CE; Phillips AG; Honer WG
Int J Neuropsychopharmacol; 2006 Aug; 9(4):457-63. PubMed ID: 16316483
[TBL] [Abstract][Full Text] [Related]
9. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.
Honer WG; Falkai P; Young C; Wang T; Xie J; Bonner J; Hu L; Boulianne GL; Luo Z; Trimble WS
Neuroscience; 1997 May; 78(1):99-110. PubMed ID: 9135092
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.
Honer WG; Falkai P; Bayer TA; Xie J; Hu L; Li HY; Arango V; Mann JJ; Dwork AJ; Trimble WS
Cereb Cortex; 2002 Apr; 12(4):349-56. PubMed ID: 11884350
[TBL] [Abstract][Full Text] [Related]
11. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.
Sawada K; Young CE; Barr AM; Longworth K; Takahashi S; Arango V; Mann JJ; Dwork AJ; Falkai P; Phillips AG; Honer WG
Mol Psychiatry; 2002; 7(5):484-92. PubMed ID: 12082566
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.
Egbujo CN; Sinclair D; Borgmann-Winter KE; Arnold SE; Turetsky BI; Hahn CG
Schizophr Res; 2015 Oct; 168(1-2):554-62. PubMed ID: 26260078
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.
Ozdemir H; Ertugrul A; Basar K; Saka E
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):62-8. PubMed ID: 22640753
[TBL] [Abstract][Full Text] [Related]
14. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations.
Oyler GA; Higgins GA; Hart RA; Battenberg E; Billingsley M; Bloom FE; Wilson MC
J Cell Biol; 1989 Dec; 109(6 Pt 1):3039-52. PubMed ID: 2592413
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.
Fatemi SH; Earle JA; Stary JM; Lee S; Sedgewick J
Neuroreport; 2001 Oct; 12(15):3257-62. PubMed ID: 11711867
[TBL] [Abstract][Full Text] [Related]
16. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Gabriel SM; Haroutunian V; Powchik P; Honer WG; Davidson M; Davies P; Davis KL
Arch Gen Psychiatry; 1997 Jun; 54(6):559-66. PubMed ID: 9193197
[TBL] [Abstract][Full Text] [Related]
17. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
Thompson PM; Egbufoama S; Vawter MP
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers of reactive plasticity.
Geddes JW; Wilson MC; Miller FD; Cotman CW
Adv Exp Med Biol; 1990; 268():425-32. PubMed ID: 2075860
[TBL] [Abstract][Full Text] [Related]
19. Reduced synaptophysin immunoreactivity in the dentate gyrus of prepulse inhibition-impaired isolation-reared rats.
Varty GB; Marsden CA; Higgins GA
Brain Res; 1999 Apr; 824(2):197-203. PubMed ID: 10196449
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study on intrinsic connectivity of hippocampus associated with positive symptom in first-episode schizophrenia.
Duan HF; Gan JL; Yang JM; Cheng ZX; Gao CY; Shi ZJ; Zhu XQ; Liang XJ; Zhao LM
Behav Brain Res; 2015 Apr; 283():78-86. PubMed ID: 25619684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
